[Effect of Royal Decree-Law 16/2012 on consumption of drugs excluded from public coverage in Navarre (Spain)]

Gac Sanit. 2015 Jan-Feb;29(1):77-8. doi: 10.1016/j.gaceta.2014.07.012. Epub 2014 Sep 8.

[Article in Spanish]

Authors

Pablo Aldaz¹, David Escalada², Blanca Martínez-Monreal², Ana Azparren³, M Eugenia Ursúa²

Affiliations

¹ Centro de Salud de San Juan, Dirección de Atención Primaria, Servicio Navarro de Salud, Pamplona, España. Electronic address: paldazhe@cfnavarra.es.
² Centro de Salud de San Juan, Dirección de Atención Primaria, Servicio Navarro de Salud, Pamplona, España.
³ Servicio de Farmacia de Atención Primaria, Servicio Navarro de Salud, Pamplona, España.

PMID: 25200375
DOI: 10.1016/j.gaceta.2014.07.012

No abstract available

Publication types

Letter

MeSH terms

Drug Utilization* / trends
Humans
Insurance, Pharmaceutical Services / legislation & jurisprudence*
Legislation, Drug*
Pharmaceutical Preparations / classification
Pharmaceutical Preparations / economics
Prescription Drugs* / economics
Prescription Fees
Spain

Substances

Pharmaceutical Preparations
Prescription Drugs